Gateway Investment Advisers LLC lowered its stake in shares of McKesson Co. (NYSE:MCK) by 15.6% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 8,991 shares of the company’s stock after selling 1,656 shares during the period. Gateway Investment Advisers LLC’s holdings in McKesson were worth $1,052,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Proficio Capital Partners LLC lifted its holdings in McKesson by 161.2% during the fourth quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock worth $25,000 after buying an additional 137 shares during the period. Bedel Financial Consulting Inc. lifted its holdings in McKesson by 165.2% during the fourth quarter. Bedel Financial Consulting Inc. now owns 236 shares of the company’s stock worth $26,000 after buying an additional 147 shares during the period. Dubuque Bank & Trust Co. lifted its holdings in McKesson by 106.7% during the first quarter. Dubuque Bank & Trust Co. now owns 341 shares of the company’s stock worth $40,000 after buying an additional 176 shares during the period. Old North State Trust LLC lifted its holdings in McKesson by 53.3% during the fourth quarter. Old North State Trust LLC now owns 391 shares of the company’s stock worth $43,000 after buying an additional 136 shares during the period. Finally, IMS Capital Management purchased a new stake in McKesson during the third quarter worth $57,000. Institutional investors own 86.60% of the company’s stock.
Shares of MCK opened at $116.61 on Wednesday. McKesson Co. has a 12 month low of $106.11 and a 12 month high of $160.84. The company has a quick ratio of 0.57, a current ratio of 1.02 and a debt-to-equity ratio of 0.81. The firm has a market cap of $22.48 billion, a PE ratio of 8.75, a price-to-earnings-growth ratio of 1.19 and a beta of 1.24.
McKesson (NYSE:MCK) last issued its quarterly earnings data on Thursday, January 31st. The company reported $3.40 EPS for the quarter, beating the consensus estimate of $3.18 by $0.22. McKesson had a positive return on equity of 27.83% and a negative net margin of 0.15%. The firm had revenue of $56.21 billion during the quarter, compared to analyst estimates of $55.27 billion. During the same quarter in the prior year, the business posted $3.41 EPS. Analysts forecast that McKesson Co. will post 13.55 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 1st were issued a dividend of $0.39 per share. The ex-dividend date of this dividend was Thursday, February 28th. This represents a $1.56 annualized dividend and a dividend yield of 1.34%. McKesson’s dividend payout ratio is presently 12.36%.
MCK has been the subject of a number of analyst reports. Zacks Investment Research lowered McKesson from a “hold” rating to a “sell” rating in a report on Thursday, January 3rd. ValuEngine lowered McKesson from a “sell” rating to a “strong sell” rating in a report on Saturday, January 5th. Barclays restated a “hold” rating and set a $124.00 target price on shares of McKesson in a report on Sunday, January 6th. UBS Group initiated coverage on McKesson in a report on Thursday, January 17th. They set a “neutral” rating and a $134.00 target price for the company. Finally, Deutsche Bank upgraded McKesson from a “sell” rating to a “hold” rating and set a $175.00 target price for the company in a report on Friday, January 25th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. McKesson currently has a consensus rating of “Hold” and a consensus target price of $134.90.
TRADEMARK VIOLATION NOTICE: This story was originally reported by Macon Daily and is the property of of Macon Daily. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://macondaily.com/2019/04/17/gateway-investment-advisers-llc-has-1-05-million-holdings-in-mckesson-co-mck.html.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Featured Article: Fundamental Analysis and Individual Investors
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.